{"title":"Highest benefit of neoadjuvant nivolumab in breast tumours with high PD-L1 expression and/or low ER expression","authors":"Marten Dooper","doi":"10.55788/b2fd44f8","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":516760,"journal":{"name":"Medicom Conference Report SABCS 2023","volume":"51 3-4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicom Conference Report SABCS 2023","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55788/b2fd44f8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}